tiprankstipranks
Trending News
More News >
Rising Biosciences Inc (RBII)
OTHER OTC:RBII
US Market

Rising Biosciences (RBII) Financial Statements

Compare
19 Followers

Rising Biosciences Financial Overview

Rising Biosciences's market cap is currently $499.00. The company's EPS TTM is $; its P/E ratio is ―; Rising Biosciences is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 20Dec 19
Income Statement
Total Revenue$ 782.28K$ 163.73K
Gross Profit$ 448.38K$ -68.94K
Operating Income$ 284.17K$ -179.26K
EBITDA$ 152.69K$ -145.74K
Net Income$ 49.76K$ -253.23K
Balance Sheet
Cash & Short-Term Investments$ 48.00K$ 763.00
Total Assets$ 640.42K$ 400.07K
Total Debt$ 1.06M$ 946.27K
Net Debt$ 1.01M$ 945.50K
Total Liabilities$ 1.73M$ 1.56M
Stockholders' Equity$ -1.09M$ -1.16M
Cash Flow
Free Cash Flow$ -70.34K$ -140.74K
Operating Cash Flow$ -70.34K$ -59.43K
Investing Cash Flow$ -6.06K$ -116.41K
Financing Cash Flow$ 123.63K$ 176.45K
Currency in USD

Rising Biosciences Earnings and Revenue History

Rising Biosciences Debt to Assets

Rising Biosciences Cash Flow

Rising Biosciences Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis